» Articles » PMID: 29657620

Characteristic Multimodal Imaging of Medication-Related Osteonecrosis of the Jaw: Comparison Between Oral and Parenteral Routes of Medication Administration

Overview
Journal Pol J Radiol
Publisher Termedia
Specialty Radiology
Date 2018 Apr 17
PMID 29657620
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To assess multimodal imaging features of medication-related osteonecrosis of the jaw (MRONJ) and to analyze the differences between oral and parenteral routes of medication administration. We retrospectively reviewed panoramic radiographs, CT, MRI, and bone scintigraphy of patients with MRONJ.

Material/methods: A retrospective study was conducted in 16 patients with MRONJ who underwent panoramic radiography, CT, MRI, and bone scintigraphy. Statistical analysis for the comparison between routes of medication administration and multimodal imaging features was performed with the Pearson's χ test.

Results: The percentage of cases with sequestrum separation was 25.0% (4/16 cases) on panoramic radiography and 81.3% (13/16 cases) on CT. The percentage of cases with periosteal bone proliferation on CT was 41.7% (5/12 cases) in the oral route of administration 100% (4/4 cases) in the parenteral route of administration (p=0.042). The percentage of cases with spread of soft tissue inflammation to buccal and other spaces on CT and MRI was 33.3% (4/12 cases) in the oral route of administration 100% (4/4 cases) in the parenteral route of administration (p=0.021).

Conclusions: The sequestrum separation on panoramic radiography in patients with MRONJ was unclear in comparison to CT. Furthermore, characteristic CT findings of patients with MRONJ in the parenteral administration group were periosteal bone proliferation and spread of soft tissue inflammation to buccal and other spaces.

Citing Articles

Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.

Tezuka Y, Ogura I Dentomaxillofac Radiol. 2023; 52(6):20230119.

PMID: 37395742 PMC: 10461260. DOI: 10.1259/dmfr.20230119.


A computer program to assess the bone scan index for Tc-99m hydroxymethylene diphosphonate: evaluation of jaw pathologies of patients with bone metastases using SPECT/CT.

Ogawa R, Ogura I Diagn Interv Radiol. 2023; 29(1):190-194.

PMID: 36960615 PMC: 10679603. DOI: 10.5152/dir.2022.21999.


CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw.

Ogura I, Minami Y, Ono J, Kanri Y, Okada Y, Igarashi K Imaging Sci Dent. 2021; 51(1):73-80.

PMID: 33828964 PMC: 8007393. DOI: 10.5624/isd.20200230.


Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Wongratwanich P, Shimabukuro K, Konishi M, Nagasaki T, Ohtsuka M, Suei Y Dentomaxillofac Radiol. 2021; 50(6):20200417.

PMID: 33411572 PMC: 8404513. DOI: 10.1259/dmfr.20200417.


Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.

Toshima H, Ogura I Dentomaxillofac Radiol. 2020; 49(8):20200043.

PMID: 32491931 PMC: 7719856. DOI: 10.1259/dmfr.20200043.


References
1.
Klingelhoffer C, Klingelhoffer M, Muller S, Ettl T, Wahlmann U . Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?. Dentomaxillofac Radiol. 2016; 45(5):20160065. PMC: 5084706. DOI: 10.1259/dmfr.20160065. View

2.
Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031. View

3.
Ferreira Leite A, Ogata F, de Melo N, Figueiredo P . Imaging findings of bisphosphonate-related osteonecrosis of the jaws: a critical review of the quantitative studies. Int J Dent. 2014; 2014:784348. PMC: 4075086. DOI: 10.1155/2014/784348. View

4.
Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N . Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings. J Comput Assist Tomogr. 2009; 33(2):298-304. DOI: 10.1097/RCT.0b013e31817e4986. View

5.
Paulo S, Abrantes A, Laranjo M, Carvalho L, Serra A, Botelho M . Bisphosphonate-related osteonecrosis of the jaw: specificities. Oncol Rev. 2015; 8(2):254. PMC: 4419650. DOI: 10.4081/oncol.2014.254. View